TABLE 2.

Summary of antibiotics against and E. coli and S. aureus. The antibacterial potential was registered in the inhibition zone diameter (mm).

Antibiotic	E. coli	S. aureus
AMC	00.00 ± 0.00	18.00 ± 0.10
CTX	25.03 ± 0.15	00.00 ± 0.00
CIP	39.86 ± 0.35	35.96 ± 0.00
FOS	19.99 ± 0.12	50.12 ± 0.01
SXT	35.00 ± 0.25	32.10 ± 0.10
PEN	00.00 ± 0.00	00.00 ± 0.00
NAL	33.91 ± 0.14	19.03 ± 0.06
SPT	25.95 ± 0.18	24.09 ± 0.08
DO	27.00 ± 0.1	37.16 ± 0.04
KMN	25.01 ± 0.09	26.93 ± 0.06
FTN	20.04 ± 0.09	14.86 ± 0.14
ENR	40.00 ± 0.12	39.11 ± 0.09
B	00.00 ± 0.00	22.03 ± 0.13
TET	14.02 ± 0.09	25.96 ± 0.07
SMN	18.04 ± 0.10	21.14 ± 0.12
CEF	00.00 ± 0.00	29.08 ± 0.07

Results are expressed as mean ± standard deviation, n = 3.

AMC, Ampicillin (10 µg); CTX, Céfotaxim (30 µg); CIP, Ciprofloxacin (5 μg); FOS, Fosfomycin (50 µg); SXT, Co-trimoxazole (25 µg); PEN, Penicillin (6 µg); NAL, Nalidixic acid (30 µg); SPT, Spectinomycin (100 µg); DO, Doxycycline (30 µg); KMN, Kanamycin (30 µg); FTN, Nitrofurantoin (300 µg); ENR, Enrofloxacin (5 µg); B, Bacitracin (6 µg); TET; Tétracyclin (30 µg); SMN, Streptomycin (10 µg); CEF, Cefepim (30 µg); E. coli, Escherichia coli; S. aureus, staphylococcus aureus.